Evaluation of the Treatment Effects of Tooth Borne Versus Bone-anchored Protraction Procedures in Class III Patients With Maxillary Deficiency

NCT ID: NCT04863404

Last Updated: 2021-04-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

42 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-15

Study Completion Date

2021-10-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this prospective randomized controlled clinical study is to compare the effects of bone-anchored and tooth borne maxillary protraction on dentofacial structures in skeletal Class III patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Today, the treatment of class III malocclusion is becoming more important due to the increased awareness of people about their appearance and the impact of appearance on the psychosocial state.

Various studies have shown that 40% of class III malocclusions are clinically caused by maxillary deficiency, 42% by mandibular excess, and 18% by a combination of maxillary deficiency and mandibular excess.

The face mask is the most effective treatment modality for class III malocclusions caused by a maxillary deficiency. The rationale for using a face mask is to apply heavy forces to the midface to advance the maxilla forward. These forces cause disarticulation by initiating resorption and apposition in the sutural articulations. However, undesirable dental effects arise from the use of tooth-borne rapid maxillary expansion (RME) during these treatments. These include loss of anchorage and incisor proclination during the mesialization of the maxillary dentition, extrusion of the upper molars and posterior mandibular rotation, and insufficient anterior displacement of the maxilla (1-3 mm).

Studies have shown that increasing the skeletal effects can reduce post-treatment relapse, one of the most important problems in orthodontics.

To increase the amount of maxillary skeletal advancement and to minimize the side effects of tooth-borne maxillary expansion and protraction, a new bone-anchored hybrid hyrax appliance has been proposed. Hybrid hyrax treatment has the following advantages over tooth-borne mechanics:

* Since the force is applied close to the center of resistance of the maxilla, counterclockwise rotation of the maxilla and related posterior mandibular rotation are not observed.
* Transversal forces are applied to premolars or deciduous molars and mini implants without the risk of periodontal damage, fenestration, and dehiscence that may occur with tooth-borne appliances are avoided.
* Mesial migration of the dentition, proclination of the upper incisors, and occupation of the necessary place for the canines to erupt are avoided.
* Treatment is minimally invasive.
* Upper and lower arches remain completely accessible for orthodontic interventions.
* Only skeletal maxillary advancement is achieved. In our study, additionally, the Alternate Rapid Maxillary Expansion and Constriction (AltRamec) protocol, which increases the skeletal effects during maxillary protraction by providing more effective disarticulation of circummaxillary sutures than conventional rapid maxillary expansion was used.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anterior Crossbite Class III Malocclusion Maxillary Deficiency

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
3 arm parallel clinical trial

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bone-anchored maxillary protraction group

Face mask with hybrid-hyrax

Group Type EXPERIMENTAL

Face mask with hybrid-hyrax

Intervention Type OTHER

Face mask with hybrid-hyrax

Tooth-borne maxillary protraction group

Face mask with conventional bonded RME

Group Type EXPERIMENTAL

Face mask with conventional bonded RME

Intervention Type OTHER

Face mask with conventional bonded RME

Control group

Control group consisting of 14 non-treated Class III malocclusion subjects

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Face mask with hybrid-hyrax

Face mask with hybrid-hyrax

Intervention Type OTHER

Face mask with conventional bonded RME

Face mask with conventional bonded RME

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Late mixed or early permanent dentition
* C3 or C4 period according to the cervical vertebral maturation method
* Presence of skeletal class III malocclusion (ANB \<0 °).
* Retrusive nasomaxillary complex (Nperp-A \<1 mm).
* Presence of dental class III malocclusion
* Normal or horizontal growth pattern (SNGoGn \<40 °).
* Negative overjet (overjet \<0)
* Good cooperation
* Absence of any systemic disease
* Periodontal health
* No previous orthodontic treatment
* No craniofacial deformity
* No neuromuscular deformity
* The absence of a congenital anomaly

Exclusion Criteria

* Poor cooperation
* Early mixed dentition
* Individuals who have passed the C4 period
* Craniofacial deformity
* Congenital anomaly
* A history of facial trauma Syndromes such as cleft lip and palate
Minimum Eligible Age

10 Years

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Izmir Katip Celebi University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Burçin Akan

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Burcin AKAN, Phd

Role: STUDY_DIRECTOR

Academician

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Izmir Katip Celebi University,Faculty of Dentistry, Department of Orthodontics

Izmir, Çiğli, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Burcin AKAN, Phd

Role: CONTACT

+90 5367103040

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Burcin Akan, Phd

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-TDU-DİŞF-0003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.